This Review summarizes preclinical and clinical evidence highlighting the potential of incretin-based drugs as treatments of neurodegenerative diseases, such as Alzheimer’s disease or Parkinson’s disease.
- Anika Vear
- Michael T. Heneka
- Christoffer Clemmensen